Valve-in-Ring Transcatheter Aortic Valve Replacement After Left Ventricular Assist Device Therapy.
Aortic regurgitation after left ventricular assist device (LVAD) implantation is a well-described problem that decreases the clinical effectiveness of LVAD therapy and may eventually prompt consideration of aortic valve replacement once the regurgitation becomes severe. Transcatheter aortic valve replacement (TAVR) is an attractive, less invasive option compared with surgical aortic valve replacement in these patients. We present the first case of a valve-in-ring TAVR for a patient with severe aortic regurgitation associated with LVAD destination therapy. Our case demonstrates that this approach is feasible in humans and can yield excellent clinical results.